Ajinomoto’s expansion in this industry will offer additional sourcing choices for manufacturers, since it will make obtainable cystine and cysteine that are produced by microbial fermentation of starches and/or sugars. The largest portion of the cystine and cysteine demand currently is met by suppliers who extract these proteins from recycleables of pet origin. ‘Our customers all over the world are increasingly more sensitive to the type and quality of raw materials used in food, pharma and cosmetic production,’ said Mike Lish, Director of Product sales and Advertising at Ajinomoto. ‘As the global leader in the amino acid fermentation production, adding this ability is a natural expansion for Ajinomoto.’ After the expansion, Ajinomoto will continue to produce some cystine and cysteine which consists of current chemical synthesis process, carried out by Nippon Protein Firm, a owned affiliate marketer of the business wholly.As the current pandemic unfolds, pregnant and postpartum women should be counseled about the importance of vaccination.21-23 Pregnant women certainly are a top-priority group for immunization against 2009 H1N1 influenza. Since the 2009 H1N1 monovalent vaccine is manufactured according to the same processes that are used for the seasonal influenza vaccine, its safety profile among pregnant women is likely to be similar to that of the seasonal influenza vaccine, which has been shown to be safe during pregnancy consistently.24 Preliminary benefits from a trial of 2009 H1N1 monovalent vaccine show a robust immune response in women that are pregnant, similar to the response in non-pregnant adults, no safety concerns have already been identified.25 Maternal vaccination may also provide a benefit to the newborn infant, with a decreased risk of respiratory infections related to influenza in both the mother and infant through the first 6 months after delivery.23 Regardless of the effects of rapid antigen lab tests, women with suspected or confirmed influenza who are pregnant or who’ve delivered within the previous 14 days should receive aggressive antiviral treatment and undergo close monitoring..